Meanwhile, it actively explores more green, safe and intelligent advanced engineering technologies in the biopharmaceutical field, such as continuous flow, micro-packed bed, metal catalysis and bio-enzyme catalysis, so as to continuously provide customers with more efficient, high-quality and cost-effective products and services.
Stereoselective synthesis and analysis of multi-chiral center drugs, meet the quality control requirements for chiral impurities.
At the project initiation stage, we focus on the stereoselective synthesis and industrialization of APIs and intermediates with multi-chiral centers, which feature complex structures and high technical barriers.
Equipped with complete hardware configurations (chiral HPLC, UPLC and GC), a rich variety of detection methods and a well-developed process control strategy, it ensures the analysis and research as well as quality control of chiral impurities.
The technology platform has advanced crystal and salt form screening and development strategies, which can quickly and effectively solve technical problems such as difficult crystallization, poor physical and chemical properties, and complex polymorphism.
Evaluate the thermodynamic properties of advantageous drug salt forms and their crystal forms through comprehensive DSC & TGA analysis
Investigate the dehydration behavior of API under different heating temperatures via TGA
Quantify impurity crystal forms in API by DSC
Evaluate the solid-state physical stability of API under different influencing factors using XRD
Developed based on molecular biotechnology, it is more environmentally friendly, features milder reactions and higher chiral stereoselectivity, effectively breaking through the limitations of traditional synthesis technologies.
Utilize multiple methods such as gene libraries and 3D modeling for molecular design, alter enzyme gene sequences, and thereby modify protein structure and function.
Achieve fermentation process optimization, strain preservation, protein production, and semi-synthetic metabolic extraction.
Targeted substitution of traditional chemical synthesis methods, providing mild and highly selective technical conditions, obtaining high quality pure products, and breaking through the limitations of synthesis.
Chemical Products
Homogeneous and heterogeneous continuous Flow & micro-packed bed technologies, these technologies reduce the risk of high-risk reactions, making pharmaceutical production more precise, safer, and more efficient.
High mass and heat transfer efficiency, enabling faster reactions
Precise process control with no scale-up effect
Less on-line material, ensuring safer reactions
Capable of withstanding harsh reaction conditions, reducing the risk of high-risk reactions.
Spherical supports with uniform size and high strength
Wide range of metal catalysts such as Pd, Pt, Ru, Ni, etc. with high activity, strong selectivity and high stability
High-efficiency catalysis, safe and controllable
Significantly reducing catalyst costs with high productivity
High degree of automation and easy operation
"Using light as a reagent", it is energy-saving, green and environmentally friendly, easy to control, highly selective, and can be applied to a variety of reactions.
Equipped with multiple light source configurations for parameter screening of reaction conditions
Microflow/continuous photocatalysis, capable of conducting multiphase chemical reactions, with rapid mixing and heat exchange
Continuous photocatalysis with cascade scale-up